BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

GenVault Corporation Announces Supply Agreement With Life Technologies (LIFE)


12/9/2009 10:21:50 AM

CARLSBAD, Calif., Dec. 9 /PRNewswire/ -- GenVault Corporation (Carlsbad, CA) today announces a supply and resale agreement with Life Technologies Corporation , under which Life Technologies will have non-exclusive access to GenTegra(TM) DNA technology. This technology platform comes in several formats that are consistent with Life Technologies' on-going efforts to promote the development and delivery of products in ways that help to protect and preserve the environment.

"By adopting the GenTegra(TM) DNA technology platform, we will be able to store and transport purified DNA from several of our products as well as make this technology available for use by our customers," said Nathan Wood, Vice President, Genomic Technologies, at Life Technologies Corporation. "This technology allows us to eliminate much of the waste associated with these processes, which promotes a safer and cleaner environment."

"Environmental sustainability is a key focus for us. Life Technologies' decision to adopt GenVault's GenTegra(TM) DNA to improve their internal and customer efficiencies will change the way DNA is managed in the future," said Dr. Wellis. "This announcement is tangible evidence of our success in moving GenVault squarely into the center of the much larger biosample stabilization, storage and transport markets. We look forward to extending the reach of our GenTegra(TM) technology platform into additional markets, formats and applications, including RNA in the fourth quarter of 2009," continued Dr. Wellis.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

David Wellis, Ph.D

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=91851

GenVault Corporation




Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->